Biocrates Overview

  • Founded
  • 2002
  • Status
  • Private
  • Employees
  • 54
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $12M
Latest Deal Amount
  • Investors
  • 5

Biocrates General Information


Developer of a metabolomics platform designed to support biomedical research for the discovery and validation of biomarkers for complex diseases. The company's platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information in a swift and reliable manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Eduard-Bodem Gasse 8
  • Innsbruck, 6020
  • Austria
+43 0512 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocrates Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) $12M 0000 Completed Generating Revenue
4. Later Stage VC 25-Mar-2010 00.000 00.000 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Jan-2008 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 28-Jun-2006 $6.33M $6.33M Completed Generating Revenue
1. Grant 01-Jan-2006 Completed Generating Revenue
To view Biocrates’s complete valuation and funding history, request access »

Biocrates Executive Team (13)

Name Title Board Seat Contact Info
Moritz Seuster Co-Chief Executive Officer, Chief Operating Officer & Chief Financial Officer
Nicolas Schauer Ph.D Co-Chief Executive Officer & Chief Scientific Officer
Therese Koal Chief Technology Officer
Matthias Scheffler Ph.D Chief Business Officer & Head, Marketing & Sales
Adelbert Roscher Co-Founder
You’re viewing 5 of 13 executive team members. Get the full list »

Biocrates Board Members (2)

Name Representing Role Since
Matthias Kromayer Ph.D MIG AG Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Biocrates Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocrates Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARAX Capital Partners Venture Capital Minority 000 0000 000000 0
Bionorica Corporation Minority 000 0000 000000 0
Global Chance Fund Venture Capital Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
European Union Government 000 0000 000000 0
To view Biocrates’s complete investors history, request access »

Biocrates Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 000000 03-Jan-2018 000000000000000000 Other Healthcare Services 0000 0000000-000000000 00.0
To view Biocrates’s complete acquisitions history, request access »